Tohoku University and R-Tech Ueno have entered into collaborative study to develop a sustained drug delivery system device (Patent Pending: International Publication Number WO2011/021594) developed by a research group led by Professor Toshiaki Abe of United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine and utilizing R-Tech Ueno compound Isopropyl Unoprostone. The system aimed to rescue retinal degeneration such as retinitis pigmentosa.

More information (Japanese)

[Contact]

(About the research)

Professor Toshiaki Abe

Department of Clinical Cell Therapy

United Centers for Advanced Research and Translational Medicine

Tohoku University Graduate School of Medicine

Tel: +81-22-717-8234

E-mail: toshi*oph.med.tohoku.ac.jp (Replace * with @)

(Public Relations)

Associate professor Fuji Nagami

Public Relations Office of Tohoku University Graduate School of Medicine

Tel: +81-22-717-7908

Fax: +81-22-717-8187

E-mail: f-nagami*med.tohoku.ac.jp (Replace * with @)